DMD Therapeutics

Seattle, WA, US

Facts

HQ
Seattle, WA, US
Sectors
Biotech, Life Sciences
Founded
2017
Stage
Seed

Is this your organization? Claim it

Seattle Serial Entrepreneur Ron Berenson’s New UW Spin‑Off DMD Therapeutics Files to Raise $600,000

Ron Berenson has launched a new Seattle biotech startup, DMD Therapeutics, which filed to raise $600,000 with Berenson listed as president; the company is a University of Washington spin-off currently operating in stealth mode. Berenson is a serial entrepreneur who leads several other biotech and medical companies and has a long history in Seattle’s biotech scene.